Meatable raises US$47M Series A to continue scaling trajectory and expand its product portfolio with beef

Consortium of life sciences and food investors including Section 32, DSM Venturing, Dr Rick Klausner, Dr Jeffery Leiden, and existing investors support Meatable for its next phase of growth.

Meatable, a Dutch cultivated meat start-up, has closed US$47 million in its Series A funding round, bringing the company’s total funding to $60 million. Meatable finalised its first showcase product in 2020, and aims to use the new funds to advance small-scale production at the Biotech Campus Delft, and to diversify its product portfolio.

The consortium consists of Dr Rick Klausner, Section 32, Dr Jeffery Leiden, and DSM Venturing, and includes existing investors, such as BlueYard Capital, Agronomics, Humboldt, and Taavet Hinrikus, showing continued support. They recognised the positive impact cultivated meat will have on climate change, see the potential of the cultivated meat marketplace, and are expecting Meatable to address the industry’s scalability and speed-to-market challenges with its opti-ox technology.

Dr Rick Kalusner, former director of the US National Cancer Institute and former executive director of global health at the Bill & Melinda Gates Foundation, sees potential in Meatable and its technology, and elaborated: “We are committed to joining Meatable in its mission to address the world’s most pressing challenges. We see a smart start-up that has accomplished a lot in a short amount of time.

“They have a great team and game-changing technology that can address the challenges around the global food insecurity issues our planet is facing. They have all the right ingredients to become the leading choice for sustainably and efficiently produced meat.”

Meatable’s platform technology enables a “fundamentally more cost effective and scalable production process”. It replicates the natural process of fat and muscle growth, in proportions that emulate traditional cuts of meat. The entire process, when fully developed, is expected to take only weeks to produce meat.

Krijn de Nood, CEO and co-founder of Meatable, added: “To be able to meet the growin demand for meat in Asia and across the world, with Asia having the biggest pork demand in the world, we need breakthrough solutions. Cultivated meat has the potential to continue to produce the product we love – meat – using a much more efficient production process. Having Rick Klausner, Jeffery Leiden, Section 32 and DSM support us in realising that potential is a huge step for Meatable.

“We are honoured to welcome a like-minded group of investors who support us on our mission – to develop, accelerate and bring to life sustainable, healthy and environmentally sound technologies that can improve the human condition. With this funding we believe we are well on our way to bringing our first products to market to sustainably satisfy the world’s appetite for meat.”

Meatable aims to produce cultivated meat, for which no animals are slaughtered, fewer greenhouse gas (GHG) emissions are released, and significantly less land and water are required. And, unlike plant-based alternatives, the end-product will provide the full experience of eating “actual” meat, with the same texture, taste and nutritional benefits.

After successfully completing its first pork showcase product, Meatable is currently focused on the further development of cultivated pork and beef. Meatable’s technology is adaptable to any cell-based species, including cows, pigs, sheep, and fish, giving the company an opportunity for further product development.